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Abstract
Exercise training (ET) and selenium (SEL) were evaluated either individually or in combination (COMBI) for their effects on expression of glucose 
(AMPK, PGC-1α, GLUT-4) and lactate metabolic proteins (LDH, MCT-1, MCT-4, COX-IV) in heart and skeletal muscles in a rodent model (Goto-Kakisaki,
GK) of diabetes. Forty GK rats either remained sedentary (SED), performed ET, received SEL, (5 μmol·kg body wt
-1·day
-1) or underwent both
ET and SEL treatment for 6 wk. ET alone, SEL alone, or COMBI resulted in a significant lowering of lactate, glucose, and insulin levels as well
as a reduction in HOMA-IR and AUC for glucose relative to SED. Additionally, ET alone, SEL alone, or COMBI increased glycogen content
and citrate synthase (CS) activities in liver and muscles. However, their effects on glycogen content and CS activity were tissue-specific. In particular,
ET alone, SEL alone, or COMBI induced upregulation of glucose (AMPK, PGC-1α, GLUT-4) and lactate (LDH, MCT-1, MCT-4, COX-IV) metabolic
proteins relative to SED. However, their effects on glucose and lactate metabolic proteins also appeared to be tissue-specific. It seemed that glucose
and lactate metabolic protein expression was not further enhanced with COMBI compared to that of ET alone or SEL alone. These data suggest
that ET alone or SEL alone or COMBI represent a practical strategy for ameliorating aberrant expression of glucose and lactate metabolic proteins
in diabetic GK rats. 
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Introduction4)
Type II diabetes is usually caused by peripheral insulin 
resistance and includes severe metabolic defects in glucose and 
lactate homeostasis such as hyperglycemia and hyperlactatemia 
[1,2]. These conditions are caused by an accumulation of glucose, 
insulin, and lactic acid in the blood, which causes the body to 
become more insulin resistant or excessively acidic. 
Several lines of evidence indicate that resting blood glucose 
and lactate levels are elevated in diabetic rats [3-5]. In particular, 
several studies have reported that glucose and lactate expression 
in muscle tissue of diabetic rats is remarkably reduced [4-6]. 
Thus, one of the treatment options for insulin resistant diabetes, 
including hyperglycemia and hyperlactatemia, is to elevate 
glucose and lactate metabolic protein expression in skeletal 
muscle.
We have evaluated interventions that improve glucose and 
lactate metabolism in blood and muscles of diabetic animals 
including diet, physical exercise, and the use of pharmaceutical 
and nutriceutical compounds. Recently, epidemiological studies 
have shown a protective association between exercise training 
or dietary antioxidants and the development of type II diabetes 
[6-8].
Exercise training or an active life style have a profound benefit 
on glucose and lactate pathogenic phenotypes of insulin-resistant 
states. Indeed, several studies have shown that a transition from 
a sedentary life-style to a simple active lifestyle may be sufficient 
to develop favorable glucose and lactate metabolic adaptations 
and ameliorate pathogenic phenotypes in patients and animals 
with diabetes [4,9]. Therefore, exercise training has been included 
in diabetic treatment plans. 
Increasing evidence indicates that diabetes may be associated 
with increased oxidative stress, and that antioxidant treatment 
may be beneficial. Selenium is a trace element that improves 
the antioxidant system by enhancing glutathione levels [10] and 
may exert beneficial effects on glucose metabolism, possibly via 
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insulin-like actions, which may delay diabetes complications 
[7,11,12]. Glutathione peroxidase activity depends on selenium 
supplementation [13]. High doses of selenium are associated with 
memory loss, muscle pain, diarrhea,, and vomiting [14], whereas 
low selenium intake is associated with impaired glucose tolerance 
and gestational hyperglycemia [15]. According to the recommended 
daily allowance and the World Health Organization, optimum 
selenium intake is 50-200 µg/day.
At present, it is unknown whether selenium treatment affects 
hyperlactatemia or if lactate levels change in the blood and 
muscles of diabetic rats following selenium treatment. Although 
it is clear that exercise training alone or selenium alone effectively 
ameliorates some pathogenic blood and muscle phenotypes in 
diabetes, there is currently no information regarding how these 
two interventions might interact when applied in combination 
to ameliorate glucose and lactate blood and muscle pathogenic 
phenotypes in a diabetic animal model that expresses human-like 
phenotypes.
Therefore, we conducted this study to determine if exercise 
training and selenium treatment in combination improves glucose 
and lactate pathogenic phenotypes of diabetes using Goto-Kakisaki 
(GK) rats, which are a highly inbred strain of Wistar rats that 
spontaneously develop type II diabetes without obesity but 
exhibit insulin resistance and hyperglycemia and resemble the 
polygenic basis for disease in the majority of patients with type 
2 diabetes [16].
Specifically, GK rats underwent a 6 wk treatment with exercise 
training and selenium individually or in combination, after which 
the levels of blood metabolic parameters and a number of proteins 
involved with glucose metabolism, such as AMP-activated protein 
kinase (AMPK), peroxisome proliferator-activated receptor 
coactivator 1α (PGC-1α), and glucose transporter 4 (GLUT-4), 
and lactate metabolism, such as lactate dehydrogenase (LDH), 
monocarboxylate transporter 1 and 4 (MCT1 and 4), and 
cytochrome oxidase IV (COX-IV) in skeletal muscles were 
determined. The results are particularly important in the context 
of designing interventions that substantially ameliorate glucose 
and lactate pathogenic phenotypes of diabetes. 
Materials and Methods
Animals and treatments 
All experimental procedures were approved by the Committee 
on Animal Research at Korea National Sport University. Eight 
week old male GK rats (n = 40; mean weight, 280.30 ± 20.35 
g) were obtained from Charles River (Yokohama, Japan) and 
cared for according to the Guiding Principles for the Care and 
Use of Animals, based on the Helsinki Declaration of 1964 
(American Physiology Society Operational Guide Revision, 
2002) [17]. The rats were studied from 46 weeks of age (n =
26, mean weight, 336.05 ± 4.13 g) to 52 weeks of age (n = 26, 
mean weight, 365.16 ± 38.23 g). 
Rats were maintained on a 12:12 hour dark-light cycle, housed 
at 22 ± 2℃ with a 50% relative humidity, and had free access 
to a standard chow diet ad libitum. The body weights of the 
animals were measured at the start of the study and after the 
training period in each group. GK rats were randomly assigned 
to one of the following groups: a sedentary control group (SED), 
an exercise trained group (ET), selenium treated group (SEL), 
or a combined selenium treated and exercise trained group 
(COMBI). 
Sodium selenite (S5261, Sigma, St. Louis, MO, USA) was 
dissolved in distilled water to a final concentration of 0.2 μmol/μ
l. Animals in the SEL groups received 5 μmol/kg body weight/ 
day of purified sodium selenite, dissolved in 0.2 ml dH2O by 
intraperitoneal injection every morning for 6 weeks, as described 
previously [18]. The SED animals received the same dose of 
dH2O. Animals in the ET group ran 50 minutes per day at 21 
m/min 5 days/week at a 0% gradient for 6 weeks. Prior to the 
treadmill ET, the rats were allowed a minimum 2 week adaptation 
period to the new environment, consisting of running for 10 
minutes a day on the treadmill (11 m/min). The COMBI animals 
performed the treadmill training protocol exactly as described 
above, and also received the daily selenium treatment. 
Intraperitoneal glucose tolerance test (IPGTT) 
Twenty-four hours after the final ET bout or selenium 
treatment, the four groups underwent an IPGTT, as previously 
described by Hamamoto et al. [19]. Rats were intraperitoneally 
administered a glucose solution (1 g/kg body weight in 0.9% 
NaCl). Blood was withdrawn from a cut at the tip of the tail 
at 0, 30, 60, 90, and 120 min after glucose administration to 
measure plasma glucose. Blood glucose levels were determined 
by the sensitive strip method using a blood glucose monitoring 
system (I-sens Co., Seoul, South Korea), and the homeostasis 
model of assessment (HOMA-IR, μIu/ml × mmol/L/22.5) was 
calculated. This latter variable is defined as an index of insulin 
resistance, and reduced values reflect an increase in whole-body 
insulin sensitivity. 
Tissue preparation 
Cardiac and skeletal muscles were excised, weighed, cleaned 
of any visible blood, frozen in liquid nitrogen, and stored until 
further biochemical analysis. 
Glycogen content 
Muscles and liver glycogen content was assayed as previously 
described by Lowry and Passonneau [20]. Briefly, 10 mg of 
soleus and plantaris muscles as well as liver samples were placed 
in 500 μl of 2 N HCl (Duksan Pure Chemical Co., Ltd., 
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neutralization with 1.5 ml of 0.66 N NaOH ( D-6100; Merck, 
Darnstadt, Germany), the liberated glucose units were assayed 
fluorometrically (Genios, TECAN, Vienna, Austria), and glycogen 
content was expressed as micromoles of glucosyl units liberated 
per gram of wet muscles and liver weight (μmol·g
-1 w·w.).
Citrate synthase (CS) 
To monitor muscle adaptation to endurance training, the soleus 
and plantaris muscles as well as the heart were assayed using 
a standard spectrophotometer method for maximal CS activity 
after 6 weeks of training in the ET rats and in SED rats. We 
determined CS activity (units g
-1 tissue) in triplicate at 30℃ for 
each muscle using methods modified from Metz et al. [5]. Fresh 
homogenates, kept on ice, were used for assays. Frozen tissues 
(5-10 mg) were homogenized on ice using 40 volumes of 
extraction buffer (pH 7.5). consisting of 50 mM Tris/HCl, 5 mM 
MgSO4, 1 mM ethylene diamine tetra-acetic acid, 1 mM reduced 
glutathione, and 0.1% Triton X-100. CS activity was estimated 
as the reduction of 5,5 dithiobis-(2-nitrobenzoic) acid (DTNB) 
at 412 nm over 2.5 min using a microplate reader (Model 550; 
Bio-Rad, Tokyo, Japan). Results are expressed in micromoles 
per minute per milligram of protein. Aliquots of original 
homogenates were further diluted by 300 for CS samples. The 
CS assay medium consisted of 100 mM
  Tris/HCl (pH 8.0), 1.0 
mM
  DTNB, 3.0 mM
  acetyl CoA and 5.0 mM oxaloacetate. The 
mM extinction coefficient of DTNB is 14.1. 
Isolation of mitochondria
Mitochondria isolated from myocardium were extracted using 
a mitochondria extraction kit (IMGENEX Corp., San Diego, CA, 
USA) as follows: 100 mg of each sample was homogenized in 
1 ml homogenizing buffer and centrifuged at 3,000 rpm for 10 
min at 4℃, and the supernatant was removed. The resulting 
supernatant was centrifuged again at 12,000 rpm for 30 min at 
4℃. The pellet was mixed with 1 ml of suspension buffer and 
then centrifuged at 12,000 rpm for 10 min at 4℃. The resulting 
pellet was mixed with 1 ml of suspension buffer for 30 min 
at 4℃. The supernatant was recovered as the mitochondrial 
fraction. 
Western blot analysis 
Proteins (80 μg/lane) prepared from the tissues of diabetic GK 
rats were separated for 90 min using electrophoresis on a 10% 
SDS/PAGE gel and then transferred to polyvinylidene membranes 
for 1 hr at 60 volts. Each membrane was separately incubated 
overnight at 4℃ with one of the following primary antibodies: 
anti-AMPK (#-2532) and p-AMPK (#-2531) antibodies (Cell 
Signaling Technology, Danvers, MA, USA, 1:1000). PGC-1α 
(sc-13067), GLUT-4 (sc-1608), LDH (sc-33781), MCT-1 (sc-14917), 
COX-IV (sc-8385), GAPDH (sc-20357) antibodies (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA; 1:1000), and MCT-4 (AB 
3314P) antibody (Chemicon, Temecula, CA, USA;1:500). The 
membranes were washed with washing buffer (150 mM NaCl, 
10 mM Tris-HCl, 0.05% Tween 20, pH 8.0) and then incubated 
with secondary antibodies: horseradish peroxidase (HRP)-conjugated 
donkey anti-goat (Santa Cruz Biotechnology, sc-2004; 1:5000) 
for GLUT-4, MCT-1, mtMCT-1, and GAPDH; HRP-conjugated 
goat anti-rabbit (Santa Cruz Biotechnology, sc-2020; 1:5000) for 
PGC-1α, LDH, mtLDH, AMPK, p-AMPK, and MCT-4; and 
HRP-conjugated goat anti-mouse (Santa Cruz Biotechnology, 
sc-2005; 1:5000) for COX-IV. The membrane blot was detected 
with an enhanced chemiluminescence Western blot analysis 
system (Santa Cruz Biotechnology), following the manufacturer's 
instructions. The density of the developed bands was scanned 
using a ChemiDoc XRS system (Bio-Rad, Hercules, CA, USA).
Biochemical analysis
Whole blood was extracted precisely 24 hours after the final 
ET or selenium treatment by cardiac puncture using an 18-gauge 
needle with a 10 ml syringe. After extraction, blood samples 
were centrifuged at 15,000 rpm, at 4℃  for 10 min, and the 
supernatants were transferred to new tubes and stored at -80℃ 
until lactate (Lactate kit, Roche Diagnostics, Indianapolis, IN, 
USA), glucose (Glucose Hexokinase kit, Bayer, Pittsburgh, PA, 
USA) and insulin (Insulin RIA kit, Linco Research Inc, St. 
Charles, MO, USA) were analyzed. 
Statistical analysis
Data were analyzed using SPSS version 18.0 (SPSS, Inc., 
Chicago, IL, USA). All values are expressed as means ± SEs. 
A two-way mixed analysis of variance (ANOVA) was used to 
evaluate statistical significance of the IPGTT. Statistical significance 
was determined using a one-way ANOVA when comparing the 
groups. A Bonferroni post hoc test was followed for all pairwise 
multiple comparisons if a statistically significant main effect was 
found. Differences were considered statistically significant at α
= 0.05.
Results
Effect of ET and SEL on body weight and metabolic parameters 
A one-way ANOVA on body weight [F(3,20) =1 2 . 7 4 ,  P <
0.001], lactate, [F(3,20) =4 . 0 8 ,  P < 0.05], glucose [F(3,20) =4 . 8 8 ,  P
< 0.01], insulin [F(3,20) = 3.42,  P < 0.05], HOMA-IR [F(3,20) =
4.15,  P < 0.05], and glucose area under curve (AUC) [F(3,20) =
6.20, P< 0.05] data indicated significant effects by group (Table 
1). The ET, SEL, and COMBI groups had significantly lower 
final body weights, and lactate, glucose, and insulin levels, as 
well as HOMA-IR and glucose AUC relative to the SED (Table 1). 208 Exercise, selenium, glucose, and lactate metabolism
SED ET SEL COMBI
Initial Body (Wt, g) 340.00 ± 65.10 332.37 ± 37.45 339.25 ± 26.86 332.60 ± 39.11
Final Body (Wt, g) 422.50 ± 79.40 345.00 ± 45.68 346.50 ± 31.39 346.64 ± 64.50
Change in Body (Wt/day, g/day) 1.96 ± 0.34 0.30 ± 0.19
a  0.17 ± 0.10
a 0.33 ± 0.60
a
Plasma Lactate (mmol/L) 2.24 ± 0.26 1.30 ± 0.09
a 1.32 ± 0.19
a 1.20 ± 0.34
c
Serum Glucose (mmol/L) 8.73 ± 0.10 6.98 ± 0.22
a  6.91 ± 0.63
a 6.86 ± 0.39
b
Serum Insulin (μU/ml) 19.90 ± 2.00 12.96 ± 1.84
a 14.21 ± 2.58
a  11.66 ± 1.12
b
HOMA-IR (mg/㎗) 7.72 ± 0.76 3.82 ± 0.37
 c 4.36 ± 0.71
c 3.50 ± 0.29
c
AUC for glucose (mg/㎗) 35,541.00 ± 1,005.82 32,352.00 ± 1,022.23
a 32,439.00 ± 834.46
 a 32,253.00 ± 2,345.12
a 
Values  are  means ± SEs  for  six  animals/group. 
aP < 0.05  vs.  SED; 
bP < 0.01  vs.  SED; 
cP < 0.001  vs.  SED
SED,  sedentary  controls;  ET,  exercise  trained;  SEL,  chronic  administration  of  selenium;  COMBI,  combined  selenium  and  exercise  treatments
Table 1. Effect of exercise training and selenium on body weight, plasma lactate, serum glucose, insulin, and lipid profiles in diabetic Goto-Kakizaki rats
Fig. 1. Effect of exercise training (ET) and selenium (SEL) treatment on glucose 
responses.  Glucose  responses  during  an  intraperitoneal  glucose  tolerance  test 
(IPGTT) in diabetic Goto-Kakizaki (GK) rats after ET, chronic treatment SEL, or SEL 
combined  with  exercise  training  (COMBI).  Values  are  means ± SEs  of  six 
animals/group.
 a P < 0.05  vs. SED; 
bP < 0.05 vs.  ET; 
cP < 0.05  vs. SEL; 
dP < 0.05 
vs.  COMBI.
(A)
(B)
Fig. 2. Effects of exercise training (ET), chronic treatment with selenium (SEL), 
or SEL combined with exercise training (COMBI) on glycogen content (A) and 
citrate synthase (CS) activity (B) in diabetic Goto-Kakizaki (GK) rats. Values are 
means±SEs of six animals/group. 
aP < 0.05 vs. SED; 
bP < 0.05 vs. ET; 
cP < 0.05 
vs.  SEL; 
dP < 0.05  vs.  COMBI.
Effect of ET and SEL on glucose response
According to a two-way mixed ANOVA, an interaction was 
observed between groups and times (0, 30, 60, 90, and 120 min) 
[F(4,12) =8 . 2 9 ,  P < 0.001]. A statistically significant difference 
over time was observed. A one-way ANOVA on glucose response 
on the 60 min [F(3,20) =7 . 6 6 ,  P < 0.01], 90 min [F(3,20) = 9.20, P
< 0.01], and 120 min [F(3,20) =1 1 . 7 5 ,  P < 0.001] data indicated 
significant group effects (Fig. 1). ET resulted in a lower glucose 
response at 60 min (P < 0.05) relative to the other groups, 
whereas ET, SEL, or COMBI resulted in a reduced glucose 
response at 90 (P < 0.05, respectively) and 120 min (P < 0.05, 
respectively) relative to the SED (Fig. 1). 
Effect of ET and SEL on glycogen content and CS activity in 
skeletal muscles and liver
A one-way ANOVA on glycogen content in the soleus [F(3,20)
= 11.85, P< 0.01] and plantaris [F(3,20) = 29.46, P< 0.001] muscles 
and liver [F(3,20) =7 6 . 9 8 ,  P < 0.001] data indicated significant 
group effects (Fig. 2A). The glycogen content was higher in the 
soleus and plantaris muscles and liver of the ET and COMBI 
groups (P < 0.05, vs. SED, respectively). COMBI resulted in a 
significantly higher glycogen content in the soleus and plantaris 
muscles and liver (P < 0.05, vs. SEL, respectively). Moreover, 
ET resulted in a significant increase in glycogen content in the 
liver (P < 0.05, vs. SEL). A one-way ANOVA on CS activity 
in the soleus [F(3,20) = 82.22,  P < 0.05] and plantaris [F(3,20) =
35.46,  P < 0.05] muscle and cardiac [F(3,20) =3 4 . 5 1 ,  P < 0.001] 
data indicated significant group effects. ET, SEL, or COMBI 
resulted in significant increases in CS activity in the soleus (P
< 0.05 vs. SED, respectively) and cardiac muscles (P <0 . 0 5 ,  
respectively, vs. SED) (Fig. 2B). Additionally, COMBI resulted 
in a significant increase in CS activity in the soleus (P <0 . 0 5  
vs. SEL). Finally, ET and COMBI induced significant increases 
in CS activity in the plantaris muscle (P < 0.05, vs. SED, 
respectively; P< 0.05, vs. SEL, respectively) (Fig. 2). Seong-Seok Kim et al. 209
(A) (B)
 
Fig. 3. Effects of exercise training (ET), chronic treatment with selenium (SEL), 
or selenium combined with exercise training (COMBI) on p-AMP-activated 
protein kinase (AMPK)/AMPK ratio, peroxisome proliferator-activated receptor 
coactivator 1α (PGC-1α), and glucose transporter 4 (GLUT-4) protein level in 
the soleus (A) and plantaris muscles (B) of diabetic Goto-Kakizaki (GK) rats. 
Values are means±SEs of six animals/group. 
aP <0.05 vs. SED; 
bP< 0.05 vs. ET; 
cP < 0.05  vs.  SEL; 
dP < 0.05  vs.  COMBI.
(A) (B)
Fig. 4. Effects of exercise training (ET), chronic treatment with selenium (SEL), 
or selenium combined with exercise training (COMBI) on lactate dehydrogenase 
(LDH), monocarboxylate transporter 1 (MCT1), and MCT-4 protein level in the 
soleus (A) and plantaris muscle (B) of diabetic Goto-Kakizaki (GK) rats. Values 
are means ± SEs of six animals/group. 
aP < 0.05 vs. SED; 
bP < 0.05 vs. ET; 
cP <
0.05  vs.  SEL; 
dP < 0.05  vs.  COMBI.
Effect of ET and SEL on AMPK phosphorylation, PGC-1α, and 
GLUT-4 proteins in the soleus and plantaris muscles
A one-way ANOVA on pAMPK/AMPK [F(3,20) = 18.36,  P <
0.001], PGC-1α [F(3,20) = 29.15, P < 0.001], and GLUT-4 [F(3,20)
= 1605.72,  P < 0.001] (Fig. 3A) in soleus muscle indicated 
significant group effects. The levels of AMPK phosphorylation, 
and PGC-1α, and GLUT-4 protein in the soleus muscle in the 
ET, SEL, and COMBI were higher than those in the SED group 
(P < 0.05, respectively). Furthermore, COMBI had significantly 
greater levels of AMPK phosphorylation and  PGC-1α  and 
GLUT-4 protein content in the soleus muscle relative to ET (P
< 0.05, respectively). Moreover, PGC-1α and GLUT-4 protein 
levels in the soleus muscle in the COMBI were higher than those 
in the SEL (P < 0.05, respectively). A one-way ANOVA on 
pAMPK/AMPK [F(3,20) = 5.65, P< 0.05], PGC-1α [F(3,20) = 29.15, 
P< 0.001], and GLUT-4 [F(3,20) =1 7 3 . 7 7 ,  P< 0.001] in plantaris 
muscle indicated significant group effects. ET, SEL, and COMBI 
resulted in a significant increase in AMPK phosphorylation and 
GLUT-4 protein levels in the plantaris muscle (P< 0.05, vs. SED, 
respectively) (Fig. 3B). Additionally, ET and COMBI had 
significantly higher PGC-1α and GLUT-4 protein levels in the 
plantaris muscle relative to the SEL (P < 0.05, respectively). 
Finally, ET and COMBI had a significantly higher PGC-1α 
protein level in the plantaris muscle relative to the SED (P <
0.05, respectively) (Fig. 3).
Effect of ET and SEL on LDH, MCT-1, and MCT-4 proteins 
in the soleus and plantaris muscles
A one-way ANOVA on LDH [F(3,20) =1 9 . 7 4 ,   P < 0.001], 
MCT-1 [F(3,20) =4 9 8 . 9 0 ,  P < 0.001], and MCT-4 [F(3,20) =1 4 . 7 2 ,  
P< 0.001] in the soleus muscle indicated significant group effects 
(Fig. 4A). ET, SEL, and COMBI resulted in significant increases 
in the LDH, MCT-1, and MCT-4 protein levels in the soleus 
muscle (P < 0.05, respectively, vs. SED). A one-way ANOVA 
on LDH [F(3,20) =8 . 2 1 ,  P < 0.01], MCT-1 [F(3,20) =5 2 . 2 4 ,  P <
0.001], and MCT-4 [F(3,20) = 27.61, P< 0.001] in plantaris muscle 
indicated significant group effects (Fig. 4B). ET, SEL, and 
COMBI resulted in significant increases in LDH and MCT-1 
protein levels in plantaris muscle (P< 0.05, vs. SED, respectively). 210 Exercise, selenium, glucose, and lactate metabolism
(A) (B)
Fig. 5. Effects of exercise training (ET), chronic treatment with selenium (SEL), 
or selenium combined with exercise training (COMBI) on mitochondrial (mt) 
lactate dehydrogenase (LDH), monocarboxylate transporter 1 (MCT-1), and 
cytochrome oxidase IV (COX- IV) protein levels in the soleus (A) and plantaris 
muscle (B) of diabetic Goto-Kakizaki (GK) rats. Values are means ± SEs of six 
animals/group. 
aP < 0.05  vs. SED; 
bP < 0.05 vs.  ET; 
cP < 0.05  vs. SEL; 
dP < 0.05 
vs.  COMBI.
(A) (B)
Fig. 6. Effects of exercise training (ET), chronic treatment with selenium (SEL), 
or selenium combined with exercise training (COMBI) on whole (A) or 
mitochondrial (B) lactate dehydrogenase (LDH), monocarboxylate transporter 1
(MCT-1), and cytochrome oxidase IV (COX- IV) protein levels in cardiac muscle 
of diabetic Goto-Kakizaki (GK) rats. Values are means±SEs of six animals/group.
aP < 0.05  vs.  SED; 
bP < 0.05  vs.  ET; 
cP < 0.05  vs.  SEL; 
dP < 0.05  vs.  COMBI.
COMBI exerted a significant increase in the MCT-4 protein level 
in plantaris muscle (P < 0.05, vs. SED; P < 0.05, vs. ET; P <
0.05, vs. SEL, respectively) (Fig. 4). 
Effect of ET and SEL on mitochondrial (mt) LDH, MCT-1, and 
COX-IV proteins in soleus and plantaris muscles 
A one-way ANOVA on mtLDH [F(3,20) =8 3 9 . 4 7 ,  P < 0.001], 
mtMCT-1 [F(3,20) =3 5 . 8 3 ,  P < 0.001], and mtCOX-IV [F(3,20) =
713.33, P < 0.001] in soleus muscle indicated significant group 
effects (Fig. 5A). ET, SEL, and COMBI resulted in significant 
increases in mtLDH, mtMCT-1, and mtCOX-IV protein levels 
in soleus muscle (P< 0.05, vs. SED, respectively). SEL induced 
a significant increase in the mtLDH protein level in the soleus 
muscle (P < 0.05, vs. ET; P< 0.05, vs. COMBI, respectively). 
A one-way ANOVA on mtLDH [F(3,20) = 144.31,  P < 0.001], 
mtMCT-1 [F(3,20) =1 0 9 . 4 7 ,  P < 0.001], and mtCOX-IV [F(3,20) =
110.35,  P < 0.001] in plantaris muscle indicated significant 
group effects (Fig. 5B). ET, SEL, and COMBI led to significant 
increases in the mtLDH and mtMCT-1 protein levels in the 
plantaris muscle (P < 0.05, vs. SED, respectively). COMBI 
resulted in a significant increase in the mtLDH protein level in 
the plantaris muscle (P < 0.05, vs. SEL, respectively). ET and 
COMBI resulted in a significant increase in the mtCOX-IV 
protein level in plantaris muscle (P < 0.05, vs. SED; P<0 . 0 5 ,  
vs.SEL, respectively) (Fig. 5).
Effect of ET and SEL on total or mtLDH, MCT-1, and COX-IV 
proteins in cardiac muscle
A one-way ANOVA on LDH [F(3,20) = 10.12, P< 0.01], mtLDH 
[F(3,20) =4 4 8 . 0 8 ,  P < 0.001], MCT-1 [F(3,20) =2 4 . 9 7 ,  P <0 . 0 0 1 ] ,  
mtMCT-1 [F(3,20) = 136.00, P < 0.001], and mtCOX-IV [F(3,20) =
47.68, P < 0.001] in cardiac muscle indicated significant group 
effects (Fig. 6A). ET and COMBI resulted in significant increases 
in LDH and MCT-1 protein levels in cardiac muscle (P < 0.05, 
vs. SED; P< 0.05, vs. SEL, respectively. ET, SEL, and COMBI 
resulted in significant increases in mtLDH and mtCOX-IV 
protein levels in cardiac muscle (P< 0.05, vs. SED, respectively). 
ET and COMBI produced a significant increase in the mtLDH 
protein level in cardiac muscle (P< 0.05, vs. SEL, respectively). 
SEL and COMBI resulted in a significant increase in the mtMCT-1 
protein level in cardiac muscle (P< 0.05, vs. SED; P< 0.05, vs. 
ET, respectively) (Fig. 6).Seong-Seok Kim et al. 211
Discussion
The benefits of ET and antioxidants are well established but 
are seldom available to people suffering from diabetes. Although 
it may not be possible to prevent the underlying disease process, 
the benefits of ET and selenium for managing patients with 
diabetes have been demonstrated. ET is regarded as a useful 
strategy to ameliorate hyperglycemia, hyperlactatemia, and 
insulin resistance in patients with diabetes [21,22,34]. Moreover, 
selenium is an essential micronutrient that improves glucose 
tolerance [15] and reduces oxidative stress [10] and insulin 
resistance in mammals [7]. 
However, despite growing evidence of the benefits of ET and 
SEL for the health and function of patients with diabetes, little 
clinical evidence supports the recommendations for ET guidelines 
and SEL supplementation in patients with diabetes. Therefore, 
we evaluated the protective effects of ET and SEL individually 
and in combination on molecular pathogenic phenotypes associated 
with type II diabetes. 
We demonstrated that ET increased muscle and liver glycogen 
content and CS activity in diabetic GK rats, while reducing 
measurable levels of plasma lactate, serum glucose, insulin, 
HOMA-IR, and the glucose AUC. These results suggest that ET 
ameliorates impaired glucose metabolism and insulin resistance 
likely occurring via muscle stimulated-insulin action to improve 
glucose tolerance, increase enzyme activity involved in glucose 
oxidation (CS), and initiate the induction of metabolic genes 
associated with aerobic glucose and lactate metabolism in 
diabetic animals. These findings are in agreement with previous 
studies [4,5,21,22]. 
Mckenzie et al. [11] reported that excessive amounts of SEL 
cause selenosis, whereas a medium dose (55 μg/day) is 
recommended for health. In our report, SEL administration in 
GK rats was 5 μmol/kg body weight/day, which is similar to 
that reported to be effective for alleviating diabetic symptoms 
in diabetic rats [18,23] and its effects on glucose and lactate 
metabolism were then evaluated. It is clear from the present 
findings that SEL alone reduced blood lactate, glucose, and 
insulin levels along with an increase in muscle CS activity, which 
could have led to increased skeletal muscle lactate clearance, 
similar to the results of Fürnsinn et al. [24] and Hwang et al. 
[18], who suggested that SEL alone may exert either beneficial 
extra-pancreatic action on hypoglycemic and hypolactatemic 
effects in diabetic animals. However, our results also suggest 
that SEL alone did not increase liver or muscle glycogen content 
compared to those in SED animals. 
COMBI reduced blood lactate, glucose, insulin levels, 
HOMA-IR, and glucose AUC as well as elevated glycogen 
content and CS activity in liver and muscles. These results 
suggest that ET leads to improved glucose homeostasis and 
oxidative metabolism and ameliorates insulin resistance in 
sedentary diabetic GK rats, which leads to a selenium treatment- 
induced insulin-like improvement in glucose homeostasis and 
oxidative metabolism similar to that reported in diabetic rats that 
have undergone ET [25,26]. However, we found no evidence 
that COMBI of diabetic GK rats beneficially modified either 
muscle glycogen content or CS activity relative to ET or SEL 
alone.
One important finding of this study was that ET alone, SEL 
alone, or the COMBI regimen was effective for significantly 
enhancing AMPK, PGC-1α, and GLUT-4 protein levels in 
skeletal muscle of diabetic GK rats. These changes were induced 
by muscle-stimulated insulin action [27,28] and insulin-like 
action on supplemented SEL [21,22] or both with a clinical 
reduction in blood metabolic parameters. 
However, the expression of AMPK, PGC-1α, and GLUT-4 
proteins in the ET alone, SEL alone, or COMBI appeared to 
be tissue-specific and not what we expected. The COMBI did 
not result in an additive effect of ET and SEL on AMPK, PGC-1
α, and GLUT-4 expression in skeletal muscle relative to ET or 
SEL alone. Nevertheless, it is clear that muscle-stimulated insulin 
action and SEL-treated insulin-like action or both increased 
muscle AMPK and GLUT-4 protein levels, possibly via 
up-regulation of the PGC-1α protein in resistant skeletal muscles.
However, these results have limitations because we did not 
measure GLUT-4 membrane localization or glucose uptake, and 
we did not measure AMPK- or PGC-1α-associated GLUT-4 
promoter activity when applied to ET alone, SEL alone, or 
COMBI. Therefore, further research is needed to identify the 
aforementioned variables in diabetic GK rats, possibly through 
mechanisms underlying the beneficial effect of ET alone, SEL 
alone, or COMBI.
Our results also showed that ET and SEL increased lactate 
metabolic proteins (LDH, MCT-1, MCT-4, COX-IV) in diabetic 
GK rats, which was associated with an increase in insulin 
sensitivity and oxidative enzymatic activities. There is evidence 
that elevated lactate levels lead to a decrease in muscle lactate 
transport capacity by down regulating known lactate metabolic 
proteins and CS activity in insulin-resistant states [4,5,29]. 
Therefore, we examined the effects of ET alone, SEL alone, or 
COMBI on the expression of proteins (LDH, MCT-1, MCT-4, 
COX-IV) involved in lactate metabolism in diabetic GK rats. 
As a result, ET increased total or mtLDH, MCT-1, and COX-IV 
proteins along with CS activity in skeletal and cardiac muscle, 
similar to the results reported by McCullagh et al. [30], Hughes 
et al. [31], Enoki et al. [4], and Metz et al. [5] who suggested 
that LDH or MCT-1, oxidative capacity, and lactate oxidation 
are strongly correlated and that upregulation of LDH, MCT-1, 
and COX-IV proteins reduces hyperlactatemia in a diabetic 
animal model after ET. 
In general, tissue specificity of MCT-4 expression is highly 
related to muscle glycolytic capacity [32]. However, our results 
showed that ET increased the MCT-4 protein only in the soleus, 
which was inconsistent with the results of studies conducted by 
Bonen et al. [32] and Juel and Halestrap [33], who suggested 
that MCT-4 is related to glycolytic muscle fibers. Therefore, 212 Exercise, selenium, glucose, and lactate metabolism
further research should identify tissue-specific MCT activity in 
diabetic GK rats, possibly via ET.
The role of SEL treatment on lactate metabolic proteins has 
not been previously evaluated in diabetic animals. We have 
provided new information regarding the potential utility of SEL 
treatment for increasing LDH, MCT-1, MCT-4, and COX-IV 
proteins in insulin-resistant muscle. A significant finding was that 
SEL treatment increased total or mtLDH and MCT-1 and 
mt-COX-IV proteins, reduced lactate level, but elevated CS 
activity in skeletal muscle relative to those in SED. In addition, 
SEL increased the mtLDH and mtMCT-1 proteins but not LDH 
and MCT-1 in cardiac muscle. Therefore, the SEL effect on total 
or mtLDH, MCT-1, and COX-IV expression appears to be 
tissue-specific. Additionally, SEL also increased the MCT-4 
protein in soleus muscle only, an adaptive process similar to that 
observed with ET in diabetic GK rats. Hence, upregulation of 
total or mtLDH, MCT-1, and MCT-4 in skeletal muscle can be 
regulated by supplemented selenium through an insulin-like 
action and a decrease in lactate, glucose, and insulin levels, 
suggesting that SEL reduces lactate level, which could be more 
related to an increase in lactate uptake. 
However, the mechanism by which SEL treatment induces an 
upregulation of lactate metabolic proteins in sedentary diabetic 
GK rats was not determined because no lactate fluxes across the 
sarcolemma or MCTs translocation were observed in either 
skeletal or cardiac muscle in the present study. Therefore, additional 
experiments are needed to understand the underlying mechanisms 
involved in the increased muscle lactate uptake that occurred in 
diabetic GK rats.
We found that COMBI induced increases in LDH, MCT-1, 
MCT-4, and COX-IV proteins in skeletal and cardiac muscles 
in diabetic GK rats, indicating that the upregulation of these 
proteins occurred in response to major changes in the specific 
activity of CS along with a significant reduction in the lactate 
level observed
  following the COMBI treatment. 
Therefore, the underlying mechanism of the upregulation in 
total and mtLDH, MCT-1, and COX-IV proteins following the 
COMBI treatment may be linked to oxidative metabolism and 
strongly related to lactate oxidation in skeletal and cardiac 
muscles. Additionally, COMBI increased MCT-4 protein in both the 
soleus and plantaris muscle, suggesting that MCT-4 upregulation 
in these muscles may have contributed to lower lactate levels, 
but clearly other mechanisms must also come into play. Therefore, 
MCT-4 is regulated in different ways by COMBI depending on 
the tissue. 
Expression of the glucose and lactate metabolic proteins was 
not further enhanced with COMBI compared to that of ET or 
SEL alone. Therefore, additional experiments are needed to 
understand the underlying mechanisms involved in the increased 
muscle lactate uptake that occurs in diabetic GK rats, because 
no fluxes in lactate across the sarcolemma or MCTs translocation 
were observed in either skeletal muscle or cardiac muscle in the 
present study. 
In conclusion, ET alone, SEL alone, or COMBI showed a 
positive effect on ameliorating pathogenic phenotypes of diabetes 
possibly by upregulating AMPK-PGC-1α and GLUT-4 and lactate 
metabolic proteins, which appeared to be tissue specific. However, 
it appeared that COMBI did not have a synergistic effect. Taken 
together, these results suggest that ET alone, SEL alone, or 
COMBI is a simple behavioral and nutriceutical intervention 
sufficient to repress hyperglycemia and hyperlactatemia in animals 
with diabetes. However, further studies are needed to determine 
the interactive benefits of ET and SEL and the mechanisms 
underlying these beneficial effects. 
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